Effects of synbiotic supplementation on microbiota-derived protein-bound uremic toxins, systemic inflammation, and biochemical parameters in patients on hemodialysis: A double-blind, placebo-controlled, randomized clinical trial.

[1]  B. Meijers,et al.  The gut–kidney axis , 2017, Pediatric Nephrology.

[2]  A. Bitla,et al.  Role of Gut-derived Uremic Toxins on Oxidative Stress and Inflammation in Patients with Chronic Kidney Disease , 2017, Indian journal of nephrology.

[3]  H. Krum,et al.  Protein-bound uremic toxins: a long overlooked culprit in cardiorenal syndrome. , 2016, American journal of physiology. Renal physiology.

[4]  M. Hedayati,et al.  Effect of flaxseed oil on serum systemic and vascular inflammation markers and oxidative stress in hemodialysis patients: a randomized controlled trial , 2016, International Urology and Nephrology.

[5]  David W. Johnson,et al.  Synbiotics Easing Renal Failure by Improving Gut Microbiology (SYNERGY): A Randomized Trial. , 2016, Clinical journal of the American Society of Nephrology : CJASN.

[6]  W. van Biesen,et al.  Exploring Protein Binding of Uremic Toxins in Patients with Different Stages of Chronic Kidney Disease and during Hemodialysis , 2015, Toxins.

[7]  J. Lugon,et al.  Early changes in serum albumin: impact on 2-year mortality in incident hemodialysis patients. , 2015, Jornal brasileiro de nefrologia : 'orgao oficial de Sociedades Brasileira e Latino-Americana de Nefrologia.

[8]  Jiun-Rong Chen,et al.  Synbiotics reduce ethanol-induced hepatic steatosis and inflammation by improving intestinal permeability and microbiota in rats. , 2015, Food & function.

[9]  D. Fouque,et al.  Gut microbiota and inflammation in chronic kidney disease patients , 2015, Clinical kidney journal.

[10]  Mai-Szu Wu,et al.  The Association of Uremic Toxins and Inflammation in Hemodialysis Patients , 2014, PloS one.

[11]  David W. Johnson,et al.  Protein-bound uremic toxins, inflammation and oxidative stress: a cross-sectional study in stage 3-4 chronic kidney disease. , 2014, Archives of medical research.

[12]  David W. Johnson,et al.  Pre-, Pro-, and Synbiotics: Do They Have a Role in Reducing Uremic Toxins? A Systematic Review and Meta-Analysis , 2012, International journal of nephrology.

[13]  N. Vaziri.  CKD impairs barrier function and alters microbial flora of the intestine: a major link to inflammation and uremic toxicity , 2012, Current opinion in nephrology and hypertension.

[14]  I. Kato,et al.  Effects of synbiotic treatment on serum level of p-cresol in haemodialysis patients: a preliminary study. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[15]  B. Meijers,et al.  The gut-kidney axis: indoxyl sulfate, p-cresyl sulfate and CKD progression. , 2011, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[16]  K. Verbeke,et al.  Uremic toxins originating from colonic microbial metabolism. , 2009, Kidney international. Supplement.

[17]  Pieter Evenepoel,et al.  A review of albumin binding in CKD. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[18]  J. Coresh,et al.  Prevalence of chronic kidney disease in the United States. , 2007, JAMA.

[19]  K. Kurokawa,et al.  Indoxyl sulfate induces skeletal resistance to parathyroid hormone in cultured osteoblastic cells. , 2007, Kidney international.

[20]  C. Miki,et al.  Immunonutritional effects during synbiotics therapy in pediatric patients with short bowel syndrome , 2007, Pediatric Surgery International.

[21]  T. Meyer,et al.  Removal of P-cresol sulfate by hemodialysis. , 2005, Journal of the American Society of Nephrology : JASN.

[22]  G. Reid,et al.  Modulation of the microbial ecology of the human colon by probiotics, prebiotics and synbiotics to enhance human health: an overview of enabling science and potential applications. , 2005, FEMS microbiology ecology.

[23]  Raymond Vanholder,et al.  Review on uremic toxins: classification, concentration, and interindividual variability. , 2003, Kidney international.

[24]  K. Taki,et al.  Bifidobacterium in gastro-resistant seamless capsule reduces serum levels of indoxyl sulfate in patients on hemodialysis. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[25]  G. Gibson,et al.  Probiotics as modulators of the gut flora , 2002, British Journal of Nutrition.

[26]  R Vanholder,et al.  Protein-bound uremic solutes: the forgotten toxins. , 2001, Kidney international. Supplement.

[27]  B E Ainsworth,et al.  Compendium of physical activities: an update of activity codes and MET intensities. , 2000, Medicine and science in sports and exercise.

[28]  E. N. Wardle,et al.  Free phenols in chronic renal failure. , 1976, Clinical nephrology.

[29]  K. Hellström,et al.  Volatile phenols in serum of uraemic patients. , 1972, Clinical science.

[30]  M. Fukagawa,et al.  Role of uremic toxins and oxidative stress in the development of chronic kidney disease-mineral and bone disorder. , 2012, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[31]  K. Verbeke,et al.  p-Cresyl sulfate serum concentrations in haemodialysis patients are reduced by the prebiotic oligofructose-enriched inulin. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[32]  K. Taki,et al.  Beneficial effects of Bifidobacteria in a gastroresistant seamless capsule on hyperhomocysteinemia in hemodialysis patients. , 2005, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

[33]  Y. Koga,et al.  Inhibition of the accumulation of uremic toxins in the blood and their precursors in the feces after oral administration of Lebenin, a lactic acid bacteria preparation, to uremic patients undergoing hemodialysis. , 1996, Nephron.

[34]  E. Friedman,et al.  Clinical Study Randomized Controlled Trial of Strain-specific Probiotic Formulation (renadyl) in Dialysis Patients , 2022 .